MCPHERSON'S LIMITED (MCP)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:

MCP - MCPHERSON'S LIMITED
FNArena Sector : Health & Nutrition
Year End: June
GICS Industry Group : Consumer Durables & Apparel
Debt/EBITDA: 1.76
Index:
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$0.435
22 Sep |
0.000 OPEN $0.44 |
0.000 HIGH $0.44 |
12,800 LOW $0.44 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 100% |
OTHER COMPANIES IN THE SAME SECTOR | |||
CLV . EBO . EXL . SIG . |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY22 Actual |
FY23 Actual |
FY24 Forecast |
FY25 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | - 3.5 | 4.3 | xxx |
DPS (cps) | xxx | 3.0 | 3.5 | xxx |
EPS Growth | xxx | N/A | N/A | xxx |
DPS Growth | xxx | - 40.0% | 16.7% | xxx |
PE Ratio | xxx | N/A | 10.2 | xxx |
Dividend Yield | xxx | N/A | 8.0% | xxx |
Div Pay Ratio(%) | xxx | N/A | 81.4% | xxx |
Last ex-div: 04/09 - ex-div 1c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2023 FactSet UK Limited. All rights reserved
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
EPS Basic | xxx | xxx | xxx | xxx | xxx | -3.5 |
DPS All | xxx | xxx | xxx | xxx | xxx | 3.0 |
Sales/Revenue | xxx | xxx | xxx | xxx | xxx | 210.3 M |
Book Value Per Share | xxx | xxx | xxx | xxx | xxx | 76.0 |
Net Operating Cash Flow | xxx | xxx | xxx | xxx | xxx | 6.5 M |
Net Profit Margin | xxx | xxx | xxx | xxx | xxx | -2.41 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Return on Capital Employed | xxx | xxx | xxx | xxx | xxx | -4.40 % |
Return on Invested Capital | xxx | xxx | xxx | xxx | xxx | -3.86 % |
Return on Assets | xxx | xxx | xxx | xxx | xxx | -2.49 % |
Return on Equity | xxx | xxx | xxx | xxx | xxx | -4.40 % |
Return on Total Capital | xxx | xxx | xxx | xxx | xxx | 5.96 % |
Free Cash Flow ex dividends | xxx | xxx | xxx | xxx | xxx | -1.0 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Short-Term Debt | xxx | xxx | xxx | xxx | xxx | 5 M |
Long Term Debt | xxx | xxx | xxx | xxx | xxx | 21 M |
Total Debt | xxx | xxx | xxx | xxx | xxx | 25 M |
Goodwill - Gross | xxx | xxx | xxx | xxx | xxx | 34 M |
Cash & Equivalents - Generic | xxx | xxx | xxx | xxx | xxx | 7 M |
Price To Book Value | xxx | xxx | xxx | xxx | xxx | 0.52 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capex | xxx | xxx | xxx | xxx | xxx | 1.8 M |
Capex % of Sales | xxx | xxx | xxx | xxx | xxx | 0.88 % |
Cost of Goods Sold | xxx | xxx | xxx | xxx | xxx | 152 M |
Selling, General & Admin. Exp & Other | xxx | xxx | xxx | xxx | xxx | 50 M |
Research & Development | xxx | xxx | xxx | xxx | xxx | - |
Investments - Total | xxx | xxx | xxx | xxx | xxx | - |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
MCP STOCK CHART

FNArena News on MCP
1 |
Australian Broker Call *Extra* Edition – Sep 08, 2023Sep 08 2023 - Daily Market Reports |
2 |
FNArena Corporate Results Monitor – 25-08-2023Aug 25 2023 - Australia |
3 |
Australian Broker Call *Extra* Edition – May 16, 2023May 16 2023 - Daily Market Reports |
4 |
Australian Broker Call *Extra* Edition – Apr 11, 2023Apr 11 2023 - Daily Market Reports |
5 |
Australian Broker Call *Extra* Edition – Sep 05, 2022Sep 05 2022 - Daily Market Reports |
Latest Health & Nutrition News
1 |
Sigma’s Win Not Neccessarily Ebos’ LossJun 14 2023 - Small Caps |
2 |
Sigma Healthcare: Brokers WaryMar 31 2022 - Australia |
3 |
Health & Wellness Boom On The ASXApr 29 2021 - Weekly Reports |
4 |
M&A Now On Sigma Healthcare’s AgendaMar 24 2021 - Australia |
5 |
McPherson’s Expands Into Herbal HealthNov 04 2020 - Small Caps |
6 |
Nine Ignored Companies Now Worth A LookSep 23 2020 - FYI |
7 |
Next Week At A Glance – 14-18 Sep 2020Sep 11 2020 - Weekly Reports |
8 |
Sigma Farewells API, Heralds New ContractDec 17 2019 - Australia |
9 |
Blackmores: Hopes Pinned On RestructuringNov 01 2019 - Australia |
10 |
Blackmores Peps Up Its Strategy For ChinaApr 17 2019 - Australia |